Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
22.93
+0.05 (0.22%)
Nov 20, 2024, 4:00 PM EST - Market closed

IART Revenue

Integra LifeSciences Holdings had revenue of $380.83M in the quarter ending September 30, 2024, a decrease of -0.41%. This brings the company's revenue in the last twelve months to $1.56B, up 1.45% year-over-year. In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, down -1.03%.

Revenue (ttm)
$1.56B
Revenue Growth
+1.45%
P/S Ratio
1.13
Revenue / Employee
$396,584
Employees
3,946
Market Cap
1.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.54B-16.09M-1.03%
Dec 31, 20221.56B15.22M0.99%
Dec 31, 20211.54B170.58M12.43%
Dec 31, 20201.37B-145.69M-9.60%
Dec 31, 20191.52B45.12M3.06%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
Azenta 656.32M
NovoCure 577.74M
AtriCure 447.57M
Galapagos NV 290.09M
Tarsus Pharmaceuticals 129.62M
RxSight 128.29M
Recursion Pharmaceuticals 65.18M
Revenue Rankings